| |
| | ANAEROBE 2006 |
 | | ANAEROBE 2006 will address both the clinical and microbiological aspects of anaerobic infections, their diagnosis, and their therapy among medical practitioners and researchers by mixing theory and practical applications. |
 | | Researchers, clinicians, and technicians from around the world are invited to attend and participate in this Congress to engage in presentations, exchanges, and dialogue on issues related to the study of anaerobes. |
 | | Initial funding and support for ANAEROBE 2006 is being provided by Schering-Plough, Wyeth, Pfizer, Ortho-McNeil, Cubist, Genzyme, Salix, Viropharma, Merck, Replidyne, Spiral Biotech, Anaerobe Systems, and R.M. Alden Research Laboratory. |
| www.anaerobe.org /2006/anaerobe2006.html (1042 words) |
|